You are here:
Würzburg, Germany – Biostatistics plays a key…
The first patient in the Phase I clinical trial…
Advanced, hard-to-treat cancers are among the…
The NCT is a long-term cooperation between the…
On July 1st, an international scientific symposium…
Personalized Oncology Begins with Diagnosis and…
Patient participation in cancer research is…
Patient involvement – how can it be practically…
PRISMA, together with the trials RATIONALE and…
Würzburg, Germany – Developing innovative…